{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:54:36Z","timestamp":1789588476932,"version":"build-2803163510"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>This case describes the successful visual restoration of a patient with end-stage Stevens\u2013Johnson syndrome (SJS) with a severely keratinized ocular surface.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This study is a case report.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A 67-year-old man with SJS secondary to allopurinol sought visual rehabilitation options. His ocular surface was severely compromised from sequelae of chronic SJS, leaving him with light perception vision bilaterally. The left eye was completely keratinized with severe ankyloblepharon. The right eye had failed penetrating keratoplasty, limbal stem cell deficiency, and a keratinized ocular surface. The patient declined both a Boston type 2 keratoprosthesis and a modified osteo-odonto keratoprosthesis. Therefore, a staged approach was pursued with (1) systemic methotrexate to control ocular surface inflammation, (2) minor salivary gland transplant to increase ocular surface lubrication, (3) lid margin mucous membrane graft to reduce keratinization, and finally, (4) Boston type 1 keratoprosthesis for visual restoration. After minor salivary gland transplant and mucous membrane graft, the Schirmer score improved from 0 mm to 3 mm with improvement in ocular surface keratinization. This approach successfully restored the vision to 20\/60, and the patient has retained the keratoprosthesis for over 2 years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Sight restoration options are limited in patients with end-stage SJS with a keratinized ocular surface, aqueous and mucin deficiency, corneal opacification, and limbal stem cell deficiency. This case demonstrates successful ocular surface rehabilitation and vision restoration in such a patient through a multifaceted approach that resulted in successful implantation and retention of a Boston type 1 keratoprosthesis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ico.0000000000003262","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T16:22:26Z","timestamp":1681921346000},"page":"912-916","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Preparing the Ocular Surface for a Boston Keratoprosthesis Type 1 Through En Bloc Minor Salivary Gland Transplantation and Mucous Membrane Grafting in End-Stage Stevens\u2013Johnson Syndrome"],"prefix":"10.1097","volume":"42","author":[{"given":"Alejandro","family":"Arboleda","sequence":"first","affiliation":[{"name":"Byers Eye Institute, Department of Ophthalmology, Stanford University, Palo Alto, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragini","family":"Phansalkar","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine, Palo Alto, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Amescua","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Shin","family":"Lee","sequence":"additional","affiliation":[{"name":"Byers Eye Institute, Department of Ophthalmology, Stanford University, Palo Alto, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Brandt","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Science, University of California, Davis, Sacramento, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Mannis","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Science, University of California, Davis, Sacramento, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Kossler","sequence":"additional","affiliation":[{"name":"Byers Eye Institute, Department of Ophthalmology, Stanford University, Palo Alto, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0407-3381","authenticated-orcid":false,"given":"Charles C.","family":"Lin","sequence":"additional","affiliation":[{"name":"Byers Eye Institute, Department of Ophthalmology, Stanford University, Palo Alto, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"R1-20250728","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens\u2013johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol."},{"key":"R2-20250728","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/ICU.0000000000000312","article-title":"Ocular manifestations of Stevens-Johnson syndrome and their management","volume":"27","author":"Saeed","year":"2016","journal-title":"Curr Opin Ophthalmol."},{"key":"R3-20250728","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0161-6420(95)30980-3","article-title":"Penetrating keratoplasty in cicatrizing conjunctival diseases","volume":"102","author":"Tugal-Tutkun","year":"1995","journal-title":"Ophthalmology"},{"key":"R4-20250728","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/ICU.0b013e3283477d0d","article-title":"Expanding indications for the Boston keratoprosthesis","volume":"22","author":"Colby","year":"2011","journal-title":"Curr Opin Ophthalmol."},{"key":"R5-20250728","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.ophtha.2010.12.032","article-title":"Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis","volume":"118","author":"Greiner","year":"2011","journal-title":"Ophthalmology"},{"key":"R6-20250728","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.ophtha.2012.11.025","article-title":"Retention of the Boston keratoprosthesis type 1: multicenter study results","volume":"120","author":"Ciolino","year":"2013","journal-title":"Ophthalmology"},{"key":"R7-20250728","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0161-6420(02)00960-0","article-title":"Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency","volume":"109","author":"Solomon","year":"2002","journal-title":"Ophthalmology"},{"key":"R8-20250728","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10384-010-0879-9","article-title":"Simultaneous deep anterior lamellar keratoplasty and limbal allograft in bilateral limbal stem cell deficiency","volume":"54","author":"Omoto","year":"2010","journal-title":"Jpn J Ophthalmol."},{"key":"R9-20250728","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003226-200101000-00003","article-title":"Keratoprosthesis: preoperative prognostic categories","volume":"20","author":"Yaghouti","year":"2001","journal-title":"Cornea"},{"key":"R10-20250728","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ajo.2007.11.002","article-title":"The Boston keratoprosthesis in Stevens-Johnson syndrome","volume":"145","author":"Sayegh","year":"2008","journal-title":"Am J Ophthalmol."},{"key":"R11-20250728","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/ICO.0000000000000619","article-title":"International outcomes of the boston type i keratoprosthesis in Stevens-Johnson syndrome","volume":"34","author":"Alexander","year":"2015","journal-title":"Cornea"},{"key":"R12-20250728","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/09273948.2016.1234624","article-title":"Boston type I keratoprosthesis implantation following autologous submandibular gland transplantation for end stage ocular surface disorders","volume":"26","author":"Gu","year":"2018","journal-title":"Ocul Immunol Inflamm."},{"key":"R13-20250728","first-page":"bcr2013202756","article-title":"Boston type 1 based keratoprosthesis (Auro Kpro) and its modification (LVP Kpro) in chronic Stevens Johnson syndrome","volume":"2014","author":"Basu","year":"2014","journal-title":"Case Rep."},{"key":"R14-20250728","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40123-021-00420-8","article-title":"Ocular surface preparation before keratoprosthesis implantation","volume":"11","author":"Krysik","year":"2022","journal-title":"Ophthalmol Ther."},{"key":"R15-20250728","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/bjo.2010.199901","article-title":"Minor salivary glands and labial mucous membrane graft in the treatment of severe symblepharon and dry eye in patients with Stevens-Johnson syndrome","volume":"96","author":"Sant'Anna","year":"2012","journal-title":"Br J Ophthalmol."},{"key":"R16-20250728","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/bjophthalmol-2020-316611","article-title":"Minor salivary gland transplantation for severe dry eye disease due to cicatrising conjunctivitis: multicentre long-term outcomes of a modified technique","volume":"105","author":"Vazirani","year":"2021","journal-title":"Br J Ophthalmol."},{"key":"R17-20250728","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ajo.2020.07.006","article-title":"Lid-related keratopathy in stevens-johnson syndrome: natural course and impact of therapeutic interventions in children and adults","volume":"219","author":"Shanbhag","year":"2020","journal-title":"Am J Ophthalmol."},{"key":"R18-20250728","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/bjo.2006.109124","article-title":"The natural history of Stevens-Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy","volume":"91","author":"De Rojas","year":"2007","journal-title":"Br J Ophthalmol."},{"key":"R19-20250728","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5693\/djo.01.2009.002","article-title":"Boston Keratoprosthesis in Stevens-Johnson syndrome: a case of using infliximab to prevent tissue necrosis","volume":"15","author":"Dohlman","year":"2009","journal-title":"Digital J Ophthalmol."},{"key":"R20-20250728","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/ICO.0000000000000911","article-title":"Incidence, risk factors, and surgical management of boston type 1 keratoprothesis corneal melts, leaks, and extrusions","volume":"35","author":"Chan","year":"2016","journal-title":"Cornea"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000003262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T22:00:27Z","timestamp":1753740027000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000003262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000003262","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"2022-09-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}